For the quarter ending 2025-09-30, CLS had -$7,900K decrease in cash & cash equivalents over the period. $88,900K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net earnings | 267,800 | 297,200 |
| Depreciation and amortization | 40,300 | 82,700 |
| Sbc | 15,600 | 41,200 |
| Total return swap (trs) fair value adjustments | 113,300 | 78,300 |
| Restructuring and other charges | 2,500 | 400 |
| Unrealized losses on hedge derivatives | -1,100 | -2,600 |
| Deferred income taxes | -1,100 | -15,000 |
| Other | -5,700 | -18,400 |
| Accounts receivable | 151,500 | 218,800 |
| Inventories | 128,600 | 157,500 |
| Other current assets | 900 | 6,400 |
| Accounts payable, accrued and other current liabilities, provisions and income taxes payable | 188,600 | 316,200 |
| Net cash provided by operating activities | 126,200 | 282,700 |
| Cash paid for business acquisition, net of cash acquired | 0 | 0 |
| Purchase of property, plant and equipment | 37,300 | 69,200 |
| Proceeds from sale of assets | 0 | 0 |
| Other | 0 | 2,500 |
| Net cash used in investing activities | -37,300 | -71,700 |
| Borrowings under revolving loans | 0 | 500,000 |
| Repayments under revolving loans | 90,000 | 410,000 |
| Borrowings under term loans | 0 | 0 |
| Repayments under term loans | 4,400 | 8,700 |
| Principal payments of finance leases | 2,400 | 5,200 |
| Proceeds from issuance of capital stock | 0 | 300 |
| Repurchase of capital stock for cancellation | 0 | 117,700 |
| Purchase of treasury stock for sbc plans | 0 | 221,600 |
| Proceeds from trs settlement | 0 | 98,600 |
| Sbc cash settlement | 0 | 156,000 |
| Debt issuance costs paid | 0 | 200 |
| Net cash used in financing activities | -96,800 | -320,500 |
| Net increase (decrease) in cash and cash equivalents | -7,900 | -109,500 |
| Cash and cash equivalents at beginning of period | 423,300 | - |
| Cash and cash equivalents at end of period | 305,900 | - |
CELESTICA INC (CLS)
CELESTICA INC (CLS)